|

Carboplatin/Paclitaxel Clinical Trials

4 actively recruiting trials across 1 location

Also known as: CarboTaxol, Neoadjuvant Platin-Taxane Regimen (alternative 1), Neoadjuvant chemotherapy, PC

Other3 trials

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
Phase 2
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
Phase 2
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
Phase 3

Little Rock, Arkansas1 trial

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.